A citation-based method for searching scientific literature

Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas, Snehasis Chowdhuri. J Biomol Struct Dyn 2022
Times Cited: 12







List of co-cited articles
97 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
41

Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors.
Vijay Kumar Bhardwaj, Rahul Singh, Jatin Sharma, Vidya Rajendran, Rituraj Purohit, Sanjay Kumar. J Biomol Struct Dyn 2021
156
33

Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations.
I Aanouz, A Belhassan, K El-Khatabi, T Lakhlifi, M El-Ldrissi, M Bouachrine. J Biomol Struct Dyn 2021
152
33


Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
33


Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.
Young Bae Ryu, Hyung Jae Jeong, Jang Hoon Kim, Young Min Kim, Ji-Young Park, Doman Kim, Thi Thanh Hanh Nguyen, Su-Jin Park, Jong Sun Chang, Ki Hun Park,[...]. Bioorg Med Chem 2010
258
25



AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
Garrett M Morris, Ruth Huey, William Lindstrom, Michel F Sanner, Richard K Belew, David S Goodsell, Arthur J Olson. J Comput Chem 2009
25

Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro.
Hongbo Liu, Fei Ye, Qi Sun, Hao Liang, Chunmei Li, Siyang Li, Roujian Lu, Baoying Huang, Wenjie Tan, Luhua Lai. J Enzyme Inhib Med Chem 2021
64
25

Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.
Saurabh Upadhyay, Praveen K Tripathi, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Ashok K Patel. Phytother Res 2020
21
25

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach.
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi. Life Sci 2020
66
25

Role of Molecular Dynamics and Related Methods in Drug Discovery.
Marco De Vivo, Matteo Masetti, Giovanni Bottegoni, Andrea Cavalli. J Med Chem 2016
397
25

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
Davide Gentile, Vincenzo Patamia, Angela Scala, Maria Teresa Sciortino, Anna Piperno, Antonio Rescifina. Mar Drugs 2020
152
25

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li,[...]. Acta Pharm Sin B 2020
25


Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
Hai-Xia Su, Sheng Yao, Wen-Feng Zhao, Min-Jun Li, Jia Liu, Wei-Juan Shang, Hang Xie, Chang-Qiang Ke, Hang-Chen Hu, Mei-Na Gao,[...]. Acta Pharmacol Sin 2020
161
25

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
25

ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.
James A Maier, Carmenza Martinez, Koushik Kasavajhala, Lauren Wickstrom, Kevin E Hauser, Carlos Simmerling. J Chem Theory Comput 2015
16

Computational methods in drug discovery.
Gregory Sliwoski, Sandeepkumar Kothiwale, Jens Meiler, Edward W Lowe. Pharmacol Rev 2013
673
16


In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis.
Hariprasad Puttaswamy, Hittanahallikoppal Gajendramurthy Gowtham, Monu Dinesh Ojha, Ajay Yadav, Gourav Choudhir, Vasantharaja Raguraman, Bhani Kongkham, Koushalya Selvaraju, Shazia Shareef, Priyanka Gehlot,[...]. Sci Rep 2020
26
16

A review on drug repurposing applicable to COVID-19.
Serena Dotolo, Anna Marabotti, Angelo Facchiano, Roberto Tagliaferri. Brief Bioinform 2021
57
16

Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure-activity relationship studies.
Vishnu Nayak Badavath, Akhil Kumar, Pralok K Samanta, Siddhartha Maji, Anik Das, Galia Blum, Anjali Jha, Anik Sen. J Biomol Struct Dyn 2022
17
16

Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B.
Xulin Pan, Ninghua Tan, Guangzhi Zeng, Yumei Zhang, Ruirui Jia. Bioorg Med Chem 2005
31
16

Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study.
Marimuthu Ragavan Rameshkumar, Purushothaman Indu, Narasingam Arunagirinathan, Babu Venkatadri, Hamed A El-Serehy, Ajaz Ahmad. Saudi J Biol Sci 2021
19
16

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
Alicia Jiménez-Alberto, Rosa María Ribas-Aparicio, Gerardo Aparicio-Ozores, Juan A Castelán-Vega. Comput Biol Chem 2020
43
16

Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity.
Yuka Kimura, Hideyuki Ito, Ryoko Ohnishi, Tsutomu Hatano. Food Chem Toxicol 2010
137
16

Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.
Konda Mani Saravanan, Haiping Zhang, Renganathan Senthil, Kevin Kumar Vijayakumar, Vignesh Sounderrajan, Yanjie Wei, Harshavardhan Shakila. J Biomol Struct Dyn 2022
7
28

PubChem 2019 update: improved access to chemical data.
Sunghwan Kim, Jie Chen, Tiejun Cheng, Asta Gindulyte, Jia He, Siqian He, Qingliang Li, Benjamin A Shoemaker, Paul A Thiessen, Bo Yu,[...]. Nucleic Acids Res 2019
16

Development and testing of a general amber force field.
Junmei Wang, Romain M Wolf, James W Caldwell, Peter A Kollman, David A Case. J Comput Chem 2004
16

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.
Irene Maffucci, Alessandro Contini. J Proteome Res 2020
29
16

The SARS-CoV-2 main protease as drug target.
Sven Ullrich, Christoph Nitsche. Bioorg Med Chem Lett 2020
239
16

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
Tian-Zi Wei, Hao Wang, Xue-Qing Wu, Yi Lu, Sheng-Hui Guan, Feng-Quan Dong, Chen-le Dong, Gu-Li Zhu, Yu-Zhou Bao, Jian Zhang,[...]. Chin J Integr Med 2020
32
16

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design.
Maria Bzówka, Karolina Mitusińska, Agata Raczyńska, Aleksandra Samol, Jack A Tuszyński, Artur Góra. Int J Mol Sci 2020
90
16

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients.
Hongyi Chen, Zhicheng Zhang, Li Wang, Zhihua Huang, Fanghua Gong, Xiaodong Li, Yahong Chen, Jinzi J Wu. Medicine (Baltimore) 2020
27
16

Open Babel: An open chemical toolbox.
Noel M O'Boyle, Michael Banck, Craig A James, Chris Morley, Tim Vandermeersch, Geoffrey R Hutchison. J Cheminform 2011
16



The Protein Data Bank.
H M Berman, J Westbrook, Z Feng, G Gilliland, T N Bhat, H Weissig, I N Shindyalov, P E Bourne. Nucleic Acids Res 2000
16

Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19.
Rajesh Patil, Rupesh Chikhale, Pukar Khanal, Nilambari Gurav, Muniappan Ayyanar, Saurabh Sinha, Satyendra Prasad, Yadu Nandan Dey, Manish Wanjari, Shailendra S Gurav. Inform Med Unlocked 2021
18
16

A Review on the Phytochemistry, Pharmacology, and Pharmacokinetics of Amentoflavone, a Naturally-Occurring Biflavonoid.
Sheng Yu, Hui Yan, Li Zhang, Mingqiu Shan, Peidong Chen, Anwei Ding, Sam Fong Yau Li. Molecules 2017
70
16

Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation.
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, Arnab Sen, Ayan Roy. J Biomol Struct Dyn 2021
23
16




Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
Pallab Kar, Vijay Kumar, Balachandar Vellingiri, Arnab Sen, Nishika Jaishee, Akash Anandraj, Himani Malhotra, Subires Bhattacharyya, Subhasish Mukhopadhyay, Masako Kinoshita,[...]. J Biomol Struct Dyn 2022
17
16


Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study.
Nayim Sepay, Aishwarya Sekar, Umesh C Halder, Abdullah Alarifi, Mohd Afzal. J Mol Struct 2021
19
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.